Total remission of multicentric lymphoma in dog with the Madison-Wisconsin protocol: Case report

Authors

DOI:

https://doi.org/10.33448/rsd-v10i9.17591

Keywords:

Lymphoma; Chemotherapy; Treatment.

Abstract

Lymphoma is a disorder of the hematopoietic system whose etiology involves a disordered proliferation of lymphoid cells, in which multicentric lymphoma is triggered by generalized lymph node enlargement. The Madison-Wisconsin protocol is one of the most used polychemotherapies in the treatment of multicenter lymphomas in dogs, being verified by the drugs cyclophosphamide, doxorubicin, vincristine and prednisone, and administered alternately over 19 weeks. This study aimed to report the efficiency of the Madison-Wisconsin therapeutic protocol in the total remission of a multicentric lymphoma in a dog. The animal assisted was a French Bulldog breed dog, which presented enlargement of the submandibular, pre-scapular, axillary, inguinal and popliteal lymph nodes and, on physical examination, the enlargement in the mesogastric region suggested splenomegaly. Cytological examination of the submandibular and popliteal lymph nodes was compatible with lymphoma. Ultrasonographic examination detected a marked increase in the spleen and liver, characterizing hepatosplenomegaly. No Doppler echocardiogram was possible to observe an increase in the left atrium. There was hematological follow-up of the patient during chemotherapy treatment and throughout the therapeutic course or changes in animals in the blood count, such as thrombocytosis and neutropenia, which required additional treatment. Without biochemical examination, there was an increase in ALT. After the end of chemotherapy, the animal presented complete remission of the neoplasm, demonstrating the therapeutic success of the Madison-Wisconsin protocol on lymphoma.

References

AArcher, T., & Sullivant, A. (2018). Top 5 Causes of Splenomegaly in Dogs. https://www.cliniciansbrief.com/article/top-5-causes-splenomegaly-dogs

Beraldo, M. R. A., Varzim, F. L .S. B., & Pulz, L. H. (2020). Linfoma Multicêntrico Canino: uma sinopse sobre os aspectos clinicopatológicos e alterações laboratoriais. Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP, 18(2).

Biller, B., Berg, J., Garrett, L., Ruslander, D., W earing, R., Abbott, B., P.., &. Bryan, C. (2016). AAHA Oncology Guidelines for Dogs and Cats. American Animal Hospital Association, 52(4), 181-204.

Brown, P. M., Tzannes, S., Nguyen, S., White, J., & Langova, V. (2017). LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma. Veterinary and Comparative Oncology, 16(1), 108–113.

Bruyette, D. S. (2020). Lymphomas. In K.E. Burgess (Org.), Clinical Small Animal Internal Medicine (Cap. 134, pp. 1231-1239). USA: John Wiley & Sons, Inc.

Burton, J. H., Garret-Mayer, E., & Thamm, D. H. (2012). Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma. Veterinary and Comparative Oncology, 11(4), 306-315.

Cápua, M. L. B., Coleta, F. E. D., Canesin, A. P. M. N., Godoy, A.V., Calazans, S. G., Miotto, M. R., Daleck, C. R., & Santana, A. E. (2011). Linfoma canino: clínica, hematologia e tratamento com o protocolo de Madison-Wisconsin. Ciência Rural, 41(7), 1245-1251.

Chun, R. (2009). Lymphoma: which chemotherapy protocol and why?. Topics in companion animal medicine, 24(3), 157-162.

Daleck, C. R., & De Nardi, A. B. (2016). Oncologia em cães e gatos. (2ª ed.). Rio de Janeiro, RJ: Roca.

Eberhardt, F., Köhler, C., Krastel, D., Winter, K., Alef, M., & Kiefer, I. (2015). Sonographisch erfassbare Milzveränderungen bei Hunden mit malignem Lymphom [Sonographically detectable splenic disorders in dogs with malignant lymphoma]. Tierarztliche Praxis, 43(4), 215-220.

Flory, A. B., Rassnick, K. M., Erb, H. N., Garrett, L. D., Northrup, N. C., Selting, K. A., P…, & Chretin, J. D. (2011). Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007). J Am Vet Med Assoc., 238(4), 501-506.

Garrett, L. D., Thamm, D. H.; Chun, R.; Dudley, R., & Vail, D. M. (2002, Junho, 28). Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. Journal of Veterinary Internal Medicine, 16(6), 704-709.

Hosoya, K., Kisseberth, W.C., Lord, L. K., Alvarez, F. J., Lara-Garcia, A., Kosarek, C. E,... & Couto, C.G. (2007). Comparison of COAP and UW-19 Protocols for Dogs with Multicentric Lymphoma. J Vet Intern Med. 21(6), 1355–1363.

Jeffreys, A. B., Knapp, D. W., Carlton, W. W., Thomas, R. M., Bonney, P. L., D...., & Lucroy, M. D. (2005, Julho, 01). Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. Journal of the American Animal Hospital Association, 41(4), 221–226.

Jia, S.S., Hou, Z.Z, H., Meng, B., & Ma, B.D. (2016). Diagnosis and pathological characteristics of canine lymphoma: report of 4 cases. Int J Clin Exp Pathol, 9(2), 2389-2395.

Laoharatchatathanin, T., Klomsatid, N., & Thermtong, P. (2019, Novembro,18). Multicentric Lymphoma in Fila Brasileiro Puppy: A Case Report. Journal of Mahanakorn Veterinary Medicine, 14(supplement), pp. 23-31.

Lee, J. J., Liao, A. T., & Wang, S. L. (2020). Outcome of Canine Multicentric Lymphoma after Single or Divided Treatment with Cyclophosphamide in Multidrug Chemotherapy. Topics in companion animal medicine, 41, 100461.

Macdonald, V. S., Thamm, D. H., Kurzman, I. D., Turek, M. M., & Vail, D. M. (2005, Outubro, 05). Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma? Journal of veterinary internal medicine, 19(5), 732–736.

Marconato, L. (2011, Abril, 02 ). The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects. The Veterinary Journal, 188(1), 34–38.

Mazaro, R. D., Rizkallah, I. P. J., Luz, F. S., Lorensetti, D. M., Cogliati, B., & Fighera, R. A. (2018). Aspectos epidemiológicos, clínicos e anatomopatológicos do linfoma folicular em cães. Pesquisa Veterinária Brasileira., 38(9), 1772-1780.

Moore, A. S., & Frimberger, A. E. (2018, Abril, 01). Usefulness of chemotherapy for the treatment of very elderly dogs with multicentric lymphoma. Journal of the American Veterinary Medical Association, 252(7), 852–859.

Morgan, E., O'connell, K., Thomson, M., & Griffin, A. (2018). Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs. Veterinary and comparative oncology, 16(4), 622–629.

Neel, J. A., Synder, L., & Grindem, C. B. (2012). Thrombocytosis: a retrospective study of 165 dogs. Veterinary Clinical Pathology, 41(2), 216-222.

Nelson, R. W. & Couto, C. G. (2015). Medicina interna de pequenos animais (5ª ed). Rio de Janeiro, RJ: Elsevier.

Oliveira, F. M. (2019). Linfoma multicêntrico em cão - relato de caso. (Trabalho de Conclusão de Curso). Universidade Federal de Santa Catarina, Curitibanos, Brasil.

Pereira, B. J., Nunes, L. C., Filho, S. M., & Costa, F. S. (2011). Avaliação dos efeitos da terapia com prednisona em cães utilizando análises ultrassonográficas, citopatológica e histopatológica. Revista Ceres Viçosa, 58(5), 561-566.

Silveira, P. S. D. (2016). Efeitos secundários da quimioterapia antineoplásica e seu impacto na qualidade de vida em cães e gatos com doença oncológica. Dissertação (Mestrado). Faculdade de Medicina Veterinária, Universidade de Lisboa.

Thamm, D. H. (2019). Novel Treatments for Lymphoma. The Veterinary clinics of North America. Small animal practice, 49(5), 903–915.

Vail, D. M., Thamm, D.H., & Liptak, J. M. (2020). Withrow and MacEwen’s Small Animal Clinical Oncology. (6a ed.). Mo. :Saunders Elsevier.

Wang, S. L., Lee, J. J., & Liao, A. T. (2016). Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. The Canadian veterinary journal,, 57(3), 271–276.

Zamokas, G., Grigonis, A., Babickaitè, L., Riłkevičienė, V., Lasienė, K. & Juodžiukynienė, N. (2016). Extramedullary hematopoiesis (EMH) and other pathological conditions in canine spleens. Med. Weter, 72(12), 768-772.

Zandvliet, M. (2016). Canine Lymphona: a review. Veterinary Quarterly. 36(2), 76-104.

Published

20/07/2021

How to Cite

LIMA, G. R. F. .; SILVA, A. T. dos S. da .; ARAÚJO, V. M. J. de .; TEIXEIRA, G. G. .; MENDES, A. B. dos S. .; ANASTÁCIO, F. D. L. .; SILVA, R. B. da .; PINHEIRO, B. Q. . Total remission of multicentric lymphoma in dog with the Madison-Wisconsin protocol: Case report. Research, Society and Development, [S. l.], v. 10, n. 9, p. e4110917591, 2021. DOI: 10.33448/rsd-v10i9.17591. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/17591. Acesso em: 21 nov. 2024.

Issue

Section

Agrarian and Biological Sciences